| ID Source | ID |
|---|---|
| PubMed CID | 10796 |
| SCHEMBL ID | 1930 |
| MeSH ID | M0541410 |
| Synonym |
|---|
| carbonic acid, dicesium salt |
| 534-17-8 |
| nsc-112218 |
| dicesium carbonate |
| cesium carbonate |
| cesium carbonate (cs2co3) |
| qqi20a14p4 , |
| unii-qqi20a14p4 |
| ec 208-591-9 |
| carbonic acid, cesium salt (1:2) |
| einecs 249-784-8 |
| nsc 112218 |
| cesium carbonate, reagentplus(r), 99% |
| cesium carbonate, cabot high-purity grade |
| cesium carbonate, 99.995% trace metals basis |
| cesium carbonate, 99.9% trace metals basis |
| carbonic acid, cesium salt |
| C2160 |
| AKOS009159424 |
| A829574 |
| carbonic acid; cesium |
| ccs2o3 |
| AKOS016015676 |
| caesium carbonate |
| einecs 208-591-9 |
| SH-002 |
| BP-11402 |
| FT-0623564 |
| SCHEMBL1930 |
| carbonic acid cesium salt (1:2) |
| cesium carbonate [mi] |
| cesiumcabonate |
| caesium carbonat |
| cesiurn carbonate |
| cesium cabonate |
| cs2co3 |
| FJDQFPXHSGXQBY-UHFFFAOYSA-L |
| caesiumcarbonate |
| cesium carbonat |
| cesiumcarbonate |
| cesium-carbonate |
| DTXSID0052178 |
| dicaesium carbonate |
| mfcd00010957 |
| cesium carbonate, puratronic? |
| cesium carbonate, puriss. p.a., >=99.0% |
| cesium carbonate, purum p.a., >=98.0% (t) |
| cesium carbonate, 99.95% trace metals basis |
| cesium carbonate, vetec(tm) reagent grade, 99% |
| cesium carbonate, p.a., 99.8% |
| cesium carbonate(granules) |
| SY001250 |
| cesium carbonate high purity grade, powder, (-20 mesh) |
| Q416923 |
| AMY31070 |
| cesium carbonate fine powder |
| dicesium;carbonate |
| SY288394 |
| cesium carbonate(powder) |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (2.70) | 29.6817 |
| 2010's | 33 (89.19) | 24.3611 |
| 2020's | 3 (8.11) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (2.70%) | 6.00% |
| Case Studies | 2 (5.41%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 34 (91.89%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||